Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits

Indian Journal of Orthopaedics

Volumn 45, Issue 1, 2011, Pages 57-62

  Thorey, Fritz ^a   Menzel, Henning ^b   Lorenz, Corinna ^b   Gross, Gerhard ^c   Hoffmann, Andrea ^a,c   Windhagen, Henning ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

BMP 2; osseointegration; TGF 2

Indexed keywords

EID: 78650183297     PISSN: 00195413     EISSN: 19983727     Source Type: Journal    
DOI: 10.4103/0019-5413.73659     Document Type: Article

References (47)

1. Sumner DR, Kienapfel H, Galante JO. Metallic implants. In: Habal MB, Reddi AH, editors. Bone Grafts and Bone Substitutes. Philadelphia: W. B. Saunders Company; 1992. p. 252-62.
2. Jacobs JJ, Sumner DR, Urban RM, Galante JO. Retrieval: Successful uncemented implants. In: Mortey BF, editor. Biological, Material and Mechanical Considerations of Joint Replacement. New York: Raven Press; 1993. p. 185-95.
3. Kontio R, Suuronen R, Konttinen YT, Hallikainen D, Lindqvist C, Kommonen B, et al. Orbital floor reconstruction with poly-L/D-lactide implants: Clinical, radiological and immunohistochemical study in sheep. Int J Oral Maxillofac Surg 2004;33:361-8.
4. Hallman M, Sennerby L, Zetterqvist L, Lundgren S. A 3-year prospective follow-up study of implant-supported fixed prostheses in patients subjected to maxillary sinus floor augmentation with a 80:20 mixture of deproteinized bovine bone and autogenous bone clinical, radiographic and resonance frequency analysis. Int J Oral Maxillofac Surg 2005;34:273-80.
5. Papalexiou V, Novaes AB Jr, Grisi MF, Souza SS, Taba M Jr, Kajiwara JK. Influence of implant microstructure on the dynamics of bone healing around immediate implants placed into periodontally infected sites. A confocal laser scanning microscopic study. Clin Oral Implants Res 2004;15:44-53.
6. Berengo M, Sivolella S, Majzoub Z, Cordioli G. Endoscopic evaluation of the bone-added osteotome sinus floor elevation procedure. Int J Oral Maxillofac Surg 2004;33:189-94.
7. Gaggl A, Rainer H, Chiari FM. Horizontal distraction of the anterior maxilla in combination with bilateral sinuslift operation: Preliminary report. Int J Oral Maxillofac Surg 2005;34:37-44.
8. van der Meij EH, Blankestijn J, Berns RM, Bun RJ, Jovanovic A, Onland JM, et al. The combined use of two endosteal implants and iliac crest onlay grafts in the severely atrophic mandible by a modified surgical approach. Int J Oral Maxillofac Surg 2005;34:152-7.
9. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-7.
10. Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, et al. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 1996;13:65-74.
11. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990;9:2085-93.
12. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-62.
13. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-9.
14. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-34.
15. Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO. Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 1995;77:1135-47.
16. Sumner DR, Turner TM, Urban RM, Leven RM, Hawkins M, Nichols EH, et al. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res 2001;19:85-94.
17. Sumner DR, Turner TM, Cohen M, Losavio P, Urban RM, Nichols EH, et al. Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration. J Bone Miner Res 2003;18:730-6.
18. Lind M, Overgaard S, Nguyen T, Ongpipattanakul B, Bunger C, Soballe K. Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop Scand 1996;67:611-6.
19. Lind M, Overgaard S, Ongpipattanakul B, Nguyen T, Bunger C, Soballe K. Transforming growth factor-beta 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: An experimental study in dogs. J Bone Joint Surg Br 1996;78:377-82.
20. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004;22:58-65.
21. Aspenberg P, Jeppsson C, Wang JS, Bostrom M. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: A comparison using bone chambers in rats. Bone 1996;19:499-503.
22. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-50.
23. Bragdon CR, Doherty AM, Rubash HE, Jasty M, Li XJ, Seeherman H, et al. The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model. Clin Orthop Relat Res 2003;417:50-61.
24. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjo UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-74.
25. Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J Arthroplasty 2000;15:339-46.
26. Soballe K, Jensen TB, Mouzin O, Kidder L, Bechtold JE. Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft. J Biomed Mater Res A 2004;71:569-76.
27. Cole BJ, Bostrom MP, Pritchard TL, Sumner DR, Tomin E, Lane JM, et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 1997;345:219-28.
28. Esenwein SA, Esenwein S, Herr G, Muhr G, Kusswetter W, Hartwig CH. Osteogenetic activity of BMP-3-coated titanium specimens of different surface texture at the orthotopic implant bed of giant rabbits. Chirurg 2001;72:1360-8.
29. Hartwig CH, Esenwein SA, Pfund A, Kusswetter DW, Herr G. Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): An animal study performed at the metaphyseal bone bed in dogs. Z Orthop Ihre Grenzgeb 2003;141:705-11.
30. Herr G, Hartwig CH, Boll C, Kusswetter W. Ectopic bone formation by composites of BMP and metal implants in rats. Acta Orthop Scand 1996;67:606-10.
31. Kawai T, Mieki A, Ohno Y, Umemura M, Kataoka H, Kurita S, et al. Osteoinductive activity of composites of bone morphogenetic protein and pure titanium. Clin Orthop Relat Res 1993;290:296-305.
32. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: A biomechanical and histological study in rats. Bone 2002;30:816-22.
33. Thorey F, Witte F, Nellesen J, Griep-Raming N, Menzel H, Gross G, et al. Improved osseointegration of titanium implants after surface coating with polymers in a rabbit model. Orthopade 2005;34:1112, 1114-7.
34. Van OH, Duyck J, Vander SJ, Van der PG, Jansen J, Wevers M, et al. Use of microfocus computerized tomography as a new technique for characterizing bone tissue around oral implants. J Oral Implantol 2000;26:5-12.
35. Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47.
36. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2,-4, and-6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-7.
37. Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999;70:1026-31.
38. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14:793-803.
39. Matin K, Senpuku H, Hanada N, Ozawa H, Ejiri S. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: A pilot study in rats. Int J Oral Maxillofac Implants 2003;18:211-7.
40. Sykaras N, Triplett RG, Nunn ME, Iacopino AM, Opperman LA. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 2001;12:339-49.
41. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737-44.
42. Sykaras N, Iacopino AM, Triplett RG, Marker VA. Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: A biomechanics study. Clin Oral Investig 2004;8:196-205.
43. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-4.
44. Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am 2006;88:806-17.
45. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-52.
46. Fromigue O, Marie PJ, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 1998;68:411-26.
47. Hungerford DS, Mont MA. Revision of the femoral component: Proximal porous coating. In: Callaghan JJ, Rosenberg AG, Rubash HE, editors. The adult hip. Philadelphia: Lippincott-Raven; 1998. p. 1503-14.